Global Cryoablation Devices Market is valued at approximately USD 374.03 million in 2022 and is anticipated to grow with a healthy growth rate of more than 13.70% over the forecast period 2023-2030. Cryoablation devices are medical instruments used to treat a variety of conditions by using extremely cold temperatures to destroy unwanted tissue. The devices work by delivering a controlled stream of liquid nitrogen or argon gas to the target tissue, which causes the tissue to freeze and ultimately die. The Cryoablation Devices Market is expanding because of factors such as the increasing prevalence of cancer, the rising prevalence of atrial fibrillation and the growing demand for minimally invasive surgeries.
The rising prevalence of cancer globally is fostering market growth, according to estimates from the International Agency for Research on Cancer (IARC), The estimated increase in the worldwide burden of cancer is 27.5 million new cases by 2040 from 1.9 million new cases in year 2021. Furthermore, by 2030, the CDC estimated that 12 million Americans would have atrial fibrillation.. In addition, atrial fibrillation was the primary diagnosis in almost 450,000 hospital admissions in the United States each year. During the projection period, it is anticipated that the market for cryoablation devices would have increased demand due to the rising prevalence of atrial fibrillation. In Addition, the rising number of technological advancements in cryoablation devices and rising spending on research and development activities are creating a lucrative opportunity for the market. However, the high cost of Cryoablation Devices may hamper the market growth.
The key regions considered for the Global Cryoablation Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to dominance of key market players, the rising prevalence of cancer and rising research and development activities. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and cancer prevalence, an increase in the number of collaborations for device development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market players included in this report are:
- Boston Scientific Corporation
- Micro Port Scientific Corporation.
- Medtronic
- COOPERSURGICAL, INC.
- ATRICURE, INC.
- BVM Medical Limited
- CPSI Biotech
- Ice Cure Medical
- METRUM CRYOFLEX Sp. z o.o.
- Sanarus Technologies
Recent Developments in the Market:
- In August 2022, Medtronic plc acquired Affera, Inc., a medical technology manufacturer. This acquisition results in the expansion of Medtronic in its ablation portfolio by comprising the cardiac navigation as well as the mapping platform.
- In April 2021, IceCure Medical Granted FDA Breakthrough Device Designation for ProSense® Cryoablation System. The FDA will offer a priority assessment and comments throughout development and commercialization under the programme. The FDA-accelerated collaborative discussion is something IceCure is looking forward to in order to hasten the commercialization of ProSense® for the treatment of benign and malignant tumours.
Global Cryoablation Devices Market Report Scope:
- Historical Data: - 2020 - 2021
- Base Year for Estimation: - 2022
- Forecast period: - 2023-2030
- Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: - Product, Application, End Use, Region
- Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.
By Product:
- Tissue Contact Probe Ablators
- Epidermal and Subcutaneous Cryoablation Systems
- Tissue Spray Probe Ablators
By Application:
- Lung Cancer
- Liver Cancer
- Breast Cancer
- Kidney Cancer
- Others
By End Use:
- Hospital
- Outpatient Facilities
- Research & Manufacturing
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
- 1.2.1. Cryoablation Devices Market, by Region, 2020-2030 (USD Million)
- 1.2.2. Cryoablation Devices Market, by Product, 2020-2030 (USD Million)
- 1.2.3. Cryoablation Devices Market, by Application, 2020-2030 (USD Million)
- 1.2.4. Cryoablation Devices Market, by End Use, 2020-2030 (USD Million)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Cryoablation Devices Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Cryoablation Devices Market Dynamics
- 3.1. Cryoablation Devices Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
- 3.1.1.1. Increasing prevalence of cancer
- 3.1.1.2. Rising prevalence of atrial fibrillation
- 3.1.1.3. Growing demand for minimally invasive surgeries
- 3.1.2. Market Challenges
- 3.1.2.1. High Cost of Cryoablation Devices
- 3.1.3. Market Opportunities
- 3.1.3.1. Rising number of technological advancements in cryoablation devices
- 3.1.3.2. Rising spending on research and development activities
Chapter 4. Global Cryoablation Devices Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Porter's 5 Force Impact Analysis
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
- 4.4. Top investment opportunity
- 4.5. Top winning strategies
- 4.6. COVID-19 Impact Analysis
- 4.7. Disruptive Trends
- 4.8. Industry Expert Perspective
- 4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Cryoablation Devices Market, by Product
- 5.1. Market Snapshot
- 5.2. Global Cryoablation Devices Market by Product, Performance - Potential Analysis
- 5.3. Global Cryoablation Devices Market Estimates & Forecasts by Product 2020-2030 (USD Million)
- 5.4. Cryoablation Devices Market, Sub Segment Analysis
- 5.4.1. Tissue Contact Probe Ablators
- 5.4.2. Epidermal and Subcutaneous Cryoablation Systems
- 5.4.3. Tissue Spray Probe Ablators
Chapter 6. Global Cryoablation Devices Market, by Application
- 6.1. Market Snapshot
- 6.2. Global Cryoablation Devices Market by Application, Performance - Potential Analysis
- 6.3. Global Cryoablation Devices Market Estimates & Forecasts by Application 2020-2030 (USD Million)
- 6.4. Cryoablation Devices Market, Sub Segment Analysis
- 6.4.1. Lung Cancer
- 6.4.2. Liver Cancer
- 6.4.3. Breast Cancer
- 6.4.4. Kidney Cancer
- 6.4.5. Others
Chapter 7. Global Cryoablation Devices Market, by End Use
- 7.1. Market Snapshot
- 7.2. Global Cryoablation Devices Market by End Use, Performance - Potential Analysis
- 7.3. Global Cryoablation Devices Market Estimates & Forecasts by End Use 2020-2030 (USD Million)
- 7.4. Cryoablation Devices Market, Sub Segment Analysis
- 7.4.1. Hospital
- 7.4.2. Outpatient Facilities
- 7.4.3. Research & Manufacturing
Chapter 8. Global Cryoablation Devices Market, Regional Analysis
- 8.1. Top Leading Countries
- 8.2. Top Emerging Countries
- 8.3. Cryoablation Devices Market, Regional Market Snapshot
- 8.4. North America Cryoablation Devices Market
- 8.4.1. U.S. Cryoablation Devices Market
- 8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
- 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
- 8.4.1.3. End Use breakdown estimates & forecasts, 2020-2030
- 8.4.2. Canada Cryoablation Devices Market
- 8.5. Europe Cryoablation Devices Market Snapshot
- 8.5.1. U.K. Cryoablation Devices Market
- 8.5.2. Germany Cryoablation Devices Market
- 8.5.3. France Cryoablation Devices Market
- 8.5.4. Spain Cryoablation Devices Market
- 8.5.5. Italy Cryoablation Devices Market
- 8.5.6. Rest of Europe Cryoablation Devices Market
- 8.6. Asia-Pacific Cryoablation Devices Market Snapshot
- 8.6.1. China Cryoablation Devices Market
- 8.6.2. India Cryoablation Devices Market
- 8.6.3. Japan Cryoablation Devices Market
- 8.6.4. Australia Cryoablation Devices Market
- 8.6.5. South Korea Cryoablation Devices Market
- 8.6.6. Rest of Asia Pacific Cryoablation Devices Market
- 8.7. Latin America Cryoablation Devices Market Snapshot
- 8.7.1. Brazil Cryoablation Devices Market
- 8.7.2. Mexico Cryoablation Devices Market
- 8.8. Middle East & Africa Cryoablation Devices Market
- 8.8.1. Saudi Arabia Cryoablation Devices Market
- 8.8.2. South Africa Cryoablation Devices Market
- 8.8.3. Rest of Middle East & Africa Cryoablation Devices Market
Chapter 9. Competitive Intelligence
- 9.1. Key Company SWOT Analysis
- 9.1.1. Company 1
- 9.1.2. Company 2
- 9.1.3. Company 3
- 9.2. Top Market Strategies
- 9.3. Company Profiles
- 9.3.1. Boston Scientific Corporation
- 9.3.1.1. Key Information
- 9.3.1.2. Overview
- 9.3.1.3. Financial (Subject to Data Availability)
- 9.3.1.4. Product Summary
- 9.3.1.5. Recent Developments
- 9.3.2. Micro Port Scientific Corporation.
- 9.3.3. Medtronic
- 9.3.4. COOPERSURGICAL, INC.
- 9.3.5. ATRICURE, INC.
- 9.3.6. BVM Medical Limited
- 9.3.7. CPSI Biotech
- 9.3.8. Ice Cure Medical
- 9.3.9. METRUM CRYOFLEX Sp. z o.o.
- 9.3.10. Sanarus Technologies
Chapter 10. Research Process
- 10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
- 10.2. Research Attributes
- 10.3. Research Assumption